Melanogenesis is a process which forms new pigment and is considered to have the function of controlling the overall pigmentation of higher animals, including man. An enhancement of melanogenesis is observed when a prolonged in vivo administration of melanocyte-stimulating hormone (MSH) is given to test animals. The mechanism through which MSH induces melanogenesis in vivo is not well understood at present. Since tyrosinase is a key enzyme involved in biosynthesis of melanin pigment and is present in appreciable quantities in pigmentary system, it seems likely that it participates in the action of MSH on pigment formation. This communication reports the in vivo effect of MSH on tyrosinase activity and melanogenesis of two different pigmentary systems, namely, the benign skin melanocytes of Rana pipiens frog and malignant B-16 mouse melanoma. A uniform hypothesis on the mechanism of induction of melanogenesis by this hormone is postulated.
the treated group had a lower reflectance reading at all stages of the experiment and a narrower range of variation among individuals as compared to the control animals. The results are shown in Figs. 1 and 2. The capacity of the skin of the treated group to respond to external stimuli remained essentially unchanged, as indicated by the unchanged increase and decrease in reflectance brought about by washing with Ringer solution and by the action of MSH, respectively. These observations may be interpreted as indicating that there was an increase of melanin content of melanosomes but no significant increase in the number of melanosomes or melanocytes. Moreover, these melanized melanosomes behaved normally toward external stimuli after being in a dispersed state for long periods of time.
Tyrosinase of Rana pipiens skin is a soluble cytoplasmic protyrosinase which requires activation by a proteolytic enzyme. Trypsin, chymotrypsin, and a fungal protease (Streptomycetes griseus) were found equally effective, indicating that the activation of the protyrosinase did not involve the cleavage of a specific type of peptide bonds. A spectrophotometric procedure measuring the formation of dopachrome from L-tyrosine was used to measure the tyrosinase activity of the skin extract. Since trypsin was included in the assay mixture, therefore, the procedure measured the total soluble tyrosinase activity regardless of the state of activation of the enzyme in the specimens. The melanin content of skin specimens was measured spectrophotometrically by solubilizing the melanin in dilute alkali after removal of proteins by peptic digestion. Figure 3 shows the melanin content and tyrosinase activity of skin specimens obtained from frogs given daily injection of MSH for 8 weeks, followed by a period of 8 weeks during which no injection was given. The tyrosinase activity of the skin decreased while the rate of melanin synthesis was elevated. An inverse relationship between the tyrosinase activity and melanin content was observed. This finding supports the hypothesis that the administration of MSH may release a bound, intracellular proteolytic enzyme which activates the inactive protyrosinase. The tyrosinase molecule, once activated, attaches itself to the protein matrix of a subcellular particle and initiates melanin synthesis, leading to the MSH-induced melanogenesis. The conversion of the soluble protyrosinase to active tyrosinase bound to subcellular particles causes a decrease of the soluble protyrosinase content of the skin as measured by the dopachrome procedure under the conditions used.
INDUCTION OF MELANOGENESIS IN B-16 MOUSE MELANOMA
Female C57BL/6J mice of the same age (6-9 weeks old) were used in this study (2) . The pigmentary system of B-16 mouse melanoma was found to be more responsive toward the action of MSH than amphibian skin melanocytes. Striking changes were observed in relatively short periods of time. On account of the short life span of the animal carrying B-16 melanoma, experiments in this study were not carried beyond 30 days after the implantation of the tumor. Mouse melanoma tyrosinase is tightly bound to melanosomes and is not readily solubilized by common laboratory aqueous buffers. Due to its insoluble nature, it was not possible to measure the enzyme activity by the spectrophotometric procedure. For this reason, we used a modification of the hydroxylation procedure (3) which is amenable to the measurement of particulate tyrosinase.
Studies were carried out to investigate the time course of induction of melanogenesis by MSH. The mice received a single injection of 2 mg of a-MSH at the beginning of the experiment and, thereafter, received no further injection. A significant increase of tyrosinase activity and melanogenesis of the tumor was observed. There were, however, marked differences in the rate and extent of enzyme induction between experiments. The time in which tyrosinase activity and melanogenesis reached the maximum value also varied widely. mum value on the 5th day. Thereafter, the enzyme activity dropped sharply to approximately twice the control level on the 9th day when the experiment was terminated. The time course of melanogenesis of the tumor followed that of the enzyme with a lag period of 2 days. It is of interest to note that the melanin content of the tumor fell rapidly to nearly the control value after the maximum melanogenesis was reached, indicating a high turnover rate of melanin in the tumor pigmentary system.
When the daily injection of a-MSH was maintained over a period of time, more extensive induction of melanogenesis and enzyme activity occurred as shown in Table 1 . The results suggest that the induction of melanogenesis was proportional to the dosage as well as to the length of administration of a-MSH. The subcellular distribution of tyrosinase activity was investigated by fractionating the tumor into subcellular fractions according to the procedure of Seiji et al. (4) . The results are shown in Table 2 . The tyrosinase activity of all subcellular fractions was increased manifold by the administration of a-MSH and more than 50% of the total increaase of tyrosinase activity was found in Fraction 2, which contained the major portion of mature melanosomes. Moreover, there was a considerable amount of enzyme activity in Fraction 4, the soluble fraction of the tumor, indicating that there are 2 types of tyrosinase activities:one is attached to subcellular particles and the other is a soluble enzyme. These observations are compatible with the hypothesis on the biosynthesis of melanosomes postulated by Seiji et al. (4) . Figure 5 the percent of the total tyrosinase activity of the tumor contributed by each subcellular fraction at various stages of the experiment. The most striking feature of these diagrams is that there was no remarkable difference between the treated and the control animals. In other words, the subcellular distribution pattern of tyrosinase activity was not significantly altered by the hormone treatment, although the tyrosinase activity of each of these subcellular fractions was increased manifold. The results of time-course studies strongly suggested that the action of a-MSH on the melanogenesis of mouse melanoma was mediated through an increase of tyrosinase activity of the tumor. The question arises as to whether the increase of tyrosinase activity came about by an increased rate of synthesis of the enzyme or by other means. If an increased synthesis did take place, it would be expected that a soluble tyrosinase was synthesized, and these tyrosinase molecules would orient themselves with structural proteins to form premelanosomes and melanosomes. Thus, we should find a remarkable increase of tyrosinase activity in the soluble fraction of the tumor at the onset of induction of the enzyme and a subsequent gradual shift of the increase to the "small" and "large" granule fractions. We observed a universal increase and an unaltered distribution pattern of tyrosinase activity among all subcellular fractions of the tumors, at early as well as late stages of the experiment, ruling out the possibility that an increased synthesis of the enzyme took place. Since the existence of a tyrosinase inhibitor, which may act as a regulator of the melanogenesis of the tumor, has been confirmed by several investigators (5-7), it is tempting to speculate that the administration of a-MSH may release an "activator" which counteracts the tyrosinase inhibitor to activate the tyrosinase activity of the tumor.
Based on these considerations, a working hypothesis may be formulated as follows: In both pigmentary systems, the action of MSH is mediated through an increase of tyrosinase activity. In amphibian-skin pigmentary system, the administration of MSH may cause a slight physiochemical change in the intracellular environments leading to the release of a bound proteolytic enzyme, which in turn activates the soluble protyrosinase. The tyrosinase, once activated, attaches itself to the protein matrix of a melanosome and initiates melanin synthesis. This scheme is consistent with the observation that, during MSH-induced melanogenesis in Rana pipiens, a decrease in the content of soluble protyrosinase of the skin occurred. On the other hand, the tyrosinase of mouse melanoma exists in a partially inhibited state under the influence of an intracellular tyrosinase inhibitor, and the administration of MSH may trigger the release of an "activator" which counteracts the inhibitor, leading to the activation of inhibited tyrosinase. This is consistent with the observation that there was a universal increase but an unaltered distribution pattern of tyrosinase activity among all subcellular fractions of the tumor during the entire period of administration of the hormone. There is ample evidence that intracellular cyclic AMP is a mediator of the transient action of MSH, involving the dispersion of melanosomes to produce skin darkening in fish and amphibians. It was also observed that MSH activated in vitro the adenylcylase system of melanoma (8) . Whether this enzyme system also plays a role in the in vivo MSHinduced melanogenesis is not known at present.
